ZDHHC14 antibody
Principal name
ZDHHC14 antibody
Alternative names for ZDHHC14 antibody
DHHC-14, NEW1CP, Zinc finger DHHC domain-containing protein 14, NEW1 domain-containing protein, Probable palmitoyltransferase ZDHHC14
Ncbi ID
NP_078906, NM_153746, NM_024630, NP_078906.2, NP_666185.3, NM_146073
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of ZDHHC14 antibody
- Kit Component:
- - KN319678G1, Zdhhc14 gRNA vector 1 in pCas-Guide vector
- KN319678G2, Zdhhc14 gRNA vector 2 in pCas-Guide vector
- KN319678D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Mungall,A.J., (2003) Nature 425 (6960), 805-811
Human HeLa; WB Suggested Anti-ZDHHC14 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Hela cell lysate; ZDHHC14 antibody - N-terminal region (ARP42628_P050) in Human HeLa cells using Western Blot
WB Suggested Anti-ZDHHC18 Antibody Titration: 0.2-1 ug/ml; Positive Control: OVCAR-3 cell lysateZDHHC18 is supported by BioGPS gene expression data to be expressed in OVCAR3
WB Suggested Anti-ZDHHC14 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:1562500; Positive Control: Hela cell lysate
Lysates
| Catalog No. | ||
|---|---|---|
| LY406943 | ZDHHC14 overexpression lysate |
|
 |
0.1 mg /
$495.00
|
|
| OriGene Technologies, Inc. | ||
| LY411109 | ZDHHC14 overexpression lysate |
|
|
0.1 mg /
$495.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR207828L2V | Lenti ORF particles, Zdhhc14 (GFP-tagged) - Mouse zinc finger, DHHC domain containing 14 (Zdhhc14), 200 uL, >10^7 TU/mL |
|
|
200 µl /
$1,180.00
|
|
| OriGene Technologies, Inc. | ||
| MR207828L1V | Lenti ORF particles, Zdhhc14 (Myc-DDK-tagged) - Mouse zinc finger, DHHC domain containing 14 (Zdhhc14), 200 uL, >10^7 TU/mL |
|
|
200 µl /
$1,050.00
|
|
| OriGene Technologies, Inc. | ||